Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
In Vitro Diagnostics

PUBLISHER: Grand View Research | PRODUCT CODE: 1171099

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1171099

Meningitis Diagnostic Testing Market Size, Share & Trends Analysis Report By Test Type (Latex Agglutination Tests, Lateral Flow Assay, PCR Assay, ELISA Tests, Culture Test), By End-user, By Region, And Segment Forecasts, 2023 - 2030

PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Meningitis Diagnostic Testing Market Growth & Trends:

The global meningitis diagnostic testing market size is expected to reach USD 154.06 million by 2030, according to a new report by Grand View Research, Inc, registering a CAGR of 3.68% over the forecast period. The growth of the market is accredited to the rising awareness among the people about early disease diagnosis and increasing demand for rapid diagnosis coupled with the high accuracy of the test. Moreover, the increasing government support to reduce the burden of disease and the rising number of diagnostic centers are other factors fueling market demand.

The increasing prevalence of infectious diseases, and HIV is increasing the risk of developing meningitis, which is increasing the demand for meningitis diagnostic tests, worldwide. For instance, according to the WHO, over 38.4 million people were living with HIV worldwide in 2021. In addition, according to CDC in 2020, around 30,635 people received HIV diagnoses in the U.S. High number of HIV infections may increase the testing rate for meningitis. Moreover, EV meningitis is estimated to result in around 30,000-50,000 hospitalizations every year in the U.S.

Thus, such a high incidence of target diseases is pushing manufacturers to develop precise diagnostic solutions. For instance, Cepheid offered Xpert EV, a fast molecular in vitro diagnostic EV test, which provides results in 2.5 hours with optimum sensitivity and specificity. Similarly, M-DiaMult of Diagenode Diagnostics is a type of PCR- CE-IVD kit that detects many bacterial infections including Neisseria meningitidis.

Meningitis infection has emerged as a global issue owing to its long-term consequences and high mortality rate. The government is offering active support to provide sophisticated diagnostic tests and treatment regimens to eradicate the disease. For instance, the Meningitis Research Foundation and the CDC offer referral diagnoses for different infectious diseases such as tuberculosis, malaria, and meningitis among others that are not available in hospitals. Thus, such government initiatives to promote the diagnosis of various infectious diseases are likely to offer lucrative growth opportunities for the market.

Furthermore, the surge in the healthcare sector developments and growing technological advancements in diagnostic tests are likely to offer robust growth opportunities for the market. For instance, in July 2022, Abacus Diagnostica, a leader in molecular diagnostic testing, launched a novel rapid PCR test in Europe markets for the quick identification of viruses causing encephalitis and meningitis. This newly launched test allows healthcare professionals to identify the most common virus those causes meningitis in a span of 70 minutes. The introduction of rapid tests with high accuracy is anticipated to propel the market growth in the coming years.

Meningitis Diagnostic Testing Market Report Highlights:

  • PCR assay segment held the largest market share in 2022 owing to a high preference for PCR tests and higher sensitivity and lower turnaround times of the test
  • Lateral flow assay is expected to be the fastest segment during the coming years due to the increasing adoption of rapid tests at different healthcare facilities
  • Hospitals segment was the leading revenue contributor during the base year and its high revenue is attributed to increasing access to novel diagnostic technologies and improved healthcare coverage
  • The diagnostic centers segment is anticipated to exhibit the fastest growth rate owing to the surge in the burden of infectious diseases and the increasing adoption of technologically advanced products
  • Asia Pacific is expected to exhibit the fastest growth over the forecast period due to rising investments in the region and ongoing trials in the region
Show more
Product Code: GVR-4-68040-009-0

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation and Scope
    • 1.1.1 Segment scope
    • 1.1.2 Regional scope
    • 1.1.3 Estimates and forecast timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased database:
    • 1.3.2 GVR's internal database
    • 1.3.3 Secondary sources
    • 1.3.4 Primary research
    • 1.3.5 Details of primary research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data analysis models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach: Commodity Flow Approach
  • 1.7 Research Assumptions
  • 1.8 List of Secondary Sources
  • 1.9 List of Abbreviations
  • 1.10 Objectives
    • 1.10.1 Objective 1
    • 1.10.2 Objective 2
    • 1.10.3 Objective 3
    • 1.10.4 Objective 4

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Competitive Insights

Chapter 3 Meningitis Diagnostic Testing Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent market
  • 3.2 Market Dynamics
    • 3.2.1 Market drivers analysis
      • 3.2.1.1 Increasing prevalence of meningitis
      • 3.2.1.2 Rise in demand for rapid diagnosis by using innovative technologies
      • 3.2.1.3 Active government support to control meningitis disease outbreak
    • 3.2.2 Market restraint analysis
      • 3.2.2.1 Stringent regulatory framework
  • 3.3 Penetration & Growth Prospect Mapping
  • 3.4 Meningitis Diagnostic Testing: Market Analysis Tools
    • 3.4.1 Industry analysis - Porter's
    • 3.4.2 PESTLE analysis
  • 3.5 Regulatory Framework
  • 3.6 Pricing Analysis

Chapter 4 Meningitis Diagnostic Testing Market Segment Analysis, By Test Type, 2018 - 2030 (USD Million)

  • 4.1 Definition and Scope
  • 4.2 Test Type Market Share Analysis, 2022 & 2030
  • 4.3 Segment Dashboard
  • 4.4 Global Meningitis Diagnostic Testing Market, by Test Type, 2018 to 2030
  • 4.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 4.5.1 Latex Agglutination
      • 4.5.1.1 Latex agglutination market, 2018 - 2030 (USD million)
    • 4.5.2 Lateral Flow Assay
      • 4.5.2.1 Lateral flow assay market, 2018 - 2030 (USD million)
    • 4.5.3 PCR Assay
      • 4.5.3.1 PCR assay market, 2018 - 2030 (USD million)
    • 4.5.4 ELISA Tests
      • 4.5.4.1 ELISA tests market, 2018 - 2030 (USD million)
    • 4.5.5 Culture Test
      • 4.5.5.1 Culture test market, 2018 - 2030 (USD million)
    • 4.5.6 Others
      • 4.5.6.1 Others market, 2018 - 2030 (USD million)

Chapter 5 Meningitis Diagnostic Testing Market Segment Analysis, By End-User 2018 - 2030 (USD Million)

  • 5.1 Definition and Scope
  • 5.2 End-User Market Share Analysis, 2022 & 2030
  • 5.3 Segment Dashboard
  • 5.4 Global Meningitis Diagnostic Testing Market, by End-User, 2018 to 2030
  • 5.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 5.5.1 Hospitals
      • 5.5.1.1 Hospitals market, 2018 - 2030 (USD million)
    • 5.5.2 Diagnostic Centers
      • 5.5.2.1 Diagnostic centers market, 2018 - 2030 (USD million)
    • 5.5.3 Others
      • 5.5.3.1 Others market, 2018 - 2030 (USD million)

Chapter 6 Meningitis Diagnostic Testing Market Segment Analysis, By Region, 2018 - 2030 (USD Million)

  • 6.1 Definition & Scope
  • 6.2 Regional Market Share Analysis, 2022 & 2030
  • 6.3 Regional Market Dashboard
  • 6.4 Regional Market Snapshot
  • 6.5 SWOT Analysis
    • 6.5.1 North America
    • 6.5.2 Europe
    • 6.5.3 Asia Pacific
    • 6.5.4 Latin America
    • 6.5.5 Middle East and Africa
  • 6.6 Market Size, & Forecasts, Revenue and Trend Analysis, 2018 to 2030
    • 6.6.1 North America
      • 6.6.1.1 North America market estimates and forecast, 2018 - 2030 (USD million)
      • 6.6.1.2 U.S.
      • 6.6.1.2.1 U.S. meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.1.3 Canada
      • 6.6.1.3.1 Canada meningitis diagnostic testing market, 2018 - 2030 (USD million)
    • 6.6.2 Europe
      • 6.6.2.1 Europe meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.2.2 U.K.
      • 6.6.2.2.1 U.K. meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.2.3 Germany
      • 6.6.2.3.1 Germany meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.2.4 Spain
      • 6.6.2.4.1 Spain meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.2.5 France
      • 6.6.2.5.1 France meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.2.6 Italy
      • 6.6.2.6.1 Italy meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.2.7 Denmark
      • 6.6.2.7.1 Denmark meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.2.8 Sweden
      • 6.6.2.8.1 Sweden meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.2.9 Norway
      • 6.6.2.9.1 Norway meningitis diagnostic testing market, 2018 - 2030 (USD million)
    • 6.6.3 Asia Pacific
      • 6.6.3.1 Asia Pacific meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.3.2 Japan
      • 6.6.3.2.1 Japan meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.3.3 China
      • 6.6.3.3.1 China meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.3.4 India
      • 6.6.3.4.1 India meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.3.5 South Korea
      • 6.6.3.5.1 South Korea meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.3.6 Australia
      • 6.6.3.6.1 Australia meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.3.7 Thailand
      • 6.6.3.7.1 Thailand meningitis diagnostic testing market, 2018 - 2030 (USD million)
    • 6.6.4 Latin America
      • 6.6.4.1 Latin America meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.4.2 Brazil
      • 6.6.4.2.1 Brazil meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.4.3 Mexico
      • 6.6.4.3.1 Mexico meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.4.4 Argentina
      • 6.6.4.4.1 Argentina meningitis diagnostic testing market, 2018 - 2030 (USD million)
    • 6.6.5 MEA
      • 6.6.5.1 MEA meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.5.2 South Africa
      • 6.6.5.2.1 South Africa meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.5.3 Saudi Arabia
      • 6.6.5.3.1 Saudi Arabia meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.5.4 UAE
      • 6.6.5.4.1 UAE meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.5.5 Kuwait
      • 6.6.5.5.1 Kuwait meningitis diagnostic testing market, 2018 - 2030 (USD million)

Chapter 7 Meningitis Diagnostic Testing Market - Competitive Analysis

  • 7.1 Recent Developments & Impact Analysis, by Key Market Participants
    • 7.1.1 Ansoff matrix
    • 7.1.2 Heat map analysis
    • 7.1.3 Major Deals and Strategic Alliances Analysis
      • 7.1.3.1 Joint Ventures
      • 7.1.3.2 Licensing Agreements
      • 7.1.3.3 Product Launches
      • 7.1.3.1 Conferences and Campaigns
  • 7.2 Company Categorization
    • 7.2.1 Innovators
    • 7.2.2 Market Leaders
  • 7.3 Vendor Landscape
    • 7.3.1 List of key distributors and channel partners
    • 7.3.2 Key customers
  • 7.4 Public Companies
    • 7.4.1 Competitive Dashboard Analysis
      • 7.4.1.1 Market Differentiators
  • 7.5 Private Companies
    • 7.5.1 List of key emerging companies
  • 7.6 Company Profiles
    • 7.6.1 Thermo Fisher Scientific, Inc.
      • 7.6.1.1 Company overview
      • 7.6.1.2 Financial performance
      • 7.6.1.3 Product benchmarking
      • 7.6.1.4 Strategic initiatives
    • 7.6.2 Bio-Rad Laboratories, Inc.
      • 7.6.2.1 Company overview
      • 7.6.2.2 Financial performance
      • 7.6.2.3 Product benchmarking
      • 7.6.2.4 Strategic initiatives
    • 7.6.3 Abbott
      • 7.6.3.1 Company overview
      • 7.6.3.2 Financial performance
      • 7.6.3.3 Product benchmarking
      • 7.6.3.4 Strategic initiatives
    • 7.6.4 ELITechGroup
      • 7.6.4.1 Company overview
      • 7.6.4.2 Financial performance
      • 7.6.4.3 Product benchmarking
      • 7.6.4.4 Strategic initiatives
    • 7.6.5 Seegene Inc.
      • 7.6.5.1 Company overview
      • 7.6.5.2 Financial performance
      • 7.6.5.3 Product benchmarking
      • 7.6.5.4 Strategic initiatives
    • 7.6.6 Luminex Corporation
      • 7.6.6.1 Company overview
      • 7.6.6.2 Financial performance
      • 7.6.6.3 Product benchmarking
      • 7.6.6.4 Strategic initiatives
    • 7.6.7 CERTEST BIOTEC
      • 7.6.7.1 Company overview
      • 7.6.7.2 Financial performance
      • 7.6.7.3 Product benchmarking
      • 7.6.7.4 Strategic initiatives
    • 7.6.8 IMMY
      • 7.6.8.1 Company overview
      • 7.6.8.2 Financial performance
      • 7.6.8.3 Product benchmarking
      • 7.6.8.4 Strategic initiatives
    • 7.6.9 Uniogen Oy
      • 7.6.9.1 Company overview
      • 7.6.9.2 Financial performance
      • 7.6.9.3 Product benchmarking
      • 7.6.9.4 Strategic initiatives
Show more
Product Code: GVR-4-68040-009-0

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Leading Market Players Anticipated to Witness Highest Growth
  • Table 4 Global Meningitis Diagnostic Testing Market, By Region, 2018 - 2030 (USD Million)
  • Table 5 Global Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 6 Global Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 7 North America Meningitis Diagnostic Testing Market, By Country, 2018 - 2030 (USD Million)
  • Table 8 North America Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 9 North America Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 10 U.S. Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 11 U.S. Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 12 Canada Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 13 Canada Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 14 Europe Meningitis Diagnostic Testing Market, By Country, 2018 - 2030 (USD Million)
  • Table 15 Europe Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 16 Europe Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 17 U.K. Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 18 U.K. Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 19 Germany Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 20 Germany Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 21 France Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 22 France Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 23 Spain Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 24 Spain Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 25 Italy Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 26 Italy Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 27 Denmark Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 28 Denmark Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 29 Norway Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 30 Norway Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 31 Sweden Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 32 Sweden Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific Meningitis Diagnostic Testing Market, By Country, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 36 Japan Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 37 Japan Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 38 China Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 39 China Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 40 India Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 41 India Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 42 Australia Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 43 Australia Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 44 South Korea Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 45 South Korea Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 46 Thailand Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 47 Thailand Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 48 Latin America Meningitis Diagnostic Testing Market, By Country, 2018 - 2030 (USD Million)
  • Table 49 Latin America Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 50 Latin America Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 51 Brazil Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 52 Brazil Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 53 Argentina Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 54 Argentina Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 55 Mexico Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 56 Mexico Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 57 Middle East and Africa Meningitis Diagnostic Testing Market, By Country, 2018 - 2030 (USD Million)
  • Table 58 Middle East and Africa Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 59 Middle East and Africa Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 60 South Africa Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 61 South Africa Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 62 Saudi Arabia Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 63 Saudi Arabia Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 64 UAE Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 65 UAE Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 66 Kuwait Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 67 Kuwait Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Meningitis diagnostic testing market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market outlook (2022)
  • Fig. 10 Strategy framework
  • Fig. 11 Market driver relevance analysis (Current & future impact)
  • Fig. 12 Market restraint relevance analysis (Current & future impact)
  • Fig. 13 Penetration & growth prospect mapping
  • Fig. 14 Porter's five forces analysis
  • Fig. 15 PESTLE analysis
  • Fig. 16 Meningitis Diagnostic Testing market: Test type movement analysis
  • Fig. 17 Meningitis Diagnostic Testing market: Test type segment dashboard
  • Fig. 18 Meningitis Diagnostic Testing market Test type outlook: Key takeaways
  • Fig. 19 Latex agglutination market, 2018 - 2030 (USD million)
  • Fig. 20 Lateral flow assay market, 2018 - 2030 (USD million)
  • Fig. 21 PCR assay market, 2018 - 2030 (USD million)
  • Fig. 22 ELISA tests market, 2018 - 2030 (USD million)
  • Fig. 23 Culture test market, 2018 - 2030 (USD million)
  • Fig. 24 Others market, 2018 - 2030 (USD million)
  • Fig. 25 Meningitis Diagnostic Testing market: End-user analysis
  • Fig. 26 Meningitis Diagnostic Testing market: End-user segment dashboard
  • Fig. 27 Meningitis Diagnostic Testing market End-user outlook: Key takeaways
  • Fig. 28 Hospitals market, 2018 - 2030 (USD million)
  • Fig. 29 Diagnostic centers market, 2018 - 2030 (USD million)
  • Fig. 30 Others market, 2018 - 2030 (USD million)
  • Fig. 31 Regional outlook, 2022 & 2030
  • Fig. 32 Regional market dashboard
  • Fig. 33 Regional market place: Key takeaways
  • Fig. 34 North America, SWOT
  • Fig. 35 Europe, SWOT
  • Fig. 36 Asia Pacific, SWOT
  • Fig. 37 Latin America, SWOT
  • Fig. 38 Middle East and Africa, SWOT
  • Fig. 39 North America
  • Fig. 40 North America meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 41 U.S.
  • Fig. 42 U.S. meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 43 Canada
  • Fig. 44 Canada meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 45 Europe
  • Fig. 46 Europe meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 47 U.K.
  • Fig. 48 U.K. meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 49 Germany
  • Fig. 50 Germany meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 51 Spain
  • Fig. 52 Spain meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 53 France
  • Fig. 54 France meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 55 Italy
  • Fig. 56 Italy meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 57 Denmark
  • Fig. 58 Denmark meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 59 Sweden
  • Fig. 60 Sweden meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 61 Norway
  • Fig. 62 Norway meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 63 Asia Pacific
  • Fig. 64 Asia Pacific meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 65 Japan
  • Fig. 66 Japan meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 67 China
  • Fig. 68 China meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 69 India
  • Fig. 70 India meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 71 South Korea
  • Fig. 72 South Korea meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 73 Australia
  • Fig. 74 Australia meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 75 Thailand
  • Fig. 76 Thailand meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 77 Latin America
  • Fig. 78 Latin America meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 79 Brazil
  • Fig. 80 Brazil meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 81 Mexico
  • Fig. 82 Mexico meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 83 Argentina
  • Fig. 84 Argentina meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 85 Middle East and Africa
  • Fig. 86 MEA meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 87 South Africa
  • Fig. 88 South Africa meningitis diagnostic testing market, 2018 - 2030 (USD Million)
  • Fig. 89 Saudi Arabia
  • Fig. 90 Saudi Arabia meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 91 UAE
  • Fig. 92 UAE meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 93 Kuwait
  • Fig. 94 Kuwait meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 95 Ansoff Matrix
  • Fig. 96 Heat map analysis
  • Fig. 97 Market differentiators
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!